Boundless Bio, Inc.BOLDNASDAQ

Revenue (LTM)

Net Income (LTM)

$-58M

+11.0% YoY

Free Cash Flow

$-47M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0	0
Gross Profit	0	0	0	-1	-1↓15.2%
Operating Income	-25	-46↓83.7%	-55↓17.9%	-73↓33.7%	-64↑13.3%
Net Income	-25	-46↓82.1%	-49↓7.7%	-65↓32.2%	-58↑11.0%
EBITDA	-25	-46↓84.9%	-54↓18.3%	-64↓19.4%	-62↑3.1%
EPS Diluted	-1.13	-2.06↓82.3%	-2.22↓7.8%	-3.85↓73.4%	-2.60↑32.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	34	11↓68.1%	24↑116.5%	27↑12.2%	18↓32.8%
Total Current Assets	75	68↓8.8%	124↑82.6%	154↑24.3%	110↓29.0%
Total Assets	114	77↓32.4%	130↑69.1%	206↑58.9%	157↓23.9%
Total Current Liabilities	4	8↑99.8%	9↑21.1%	8↓13.1%	13↑54.1%
Total Liabilities	152	159↑4.4%	257↑62.1%	56↓78.3%	58↑4.7%
Total Equity	-38	-82↓113.9%	-127↓55.6%	151↑218.5%	99↓34.5%
Total Debt	0	5↑1274.8%	2↓57.7%	48↑2070.0%	49↑2.9%
Net Debt	-34	-6↑83.0%	-22↓272.9%	21↑197.8%	31↑48.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-23	-40↓70.3%	-47↓18.3%	-61↓29.8%	-47↑23.3%
Capital Expenditure	-2	-1↑47.6%	-1↑40.6%	-3↓300.6%	-1↑78.5%
Free Cash Flow	-25	-41↓60.8%	-47↓16.8%	-63↓33.5%	-47↑25.5%
Stock-Based Comp	1	2↑97.8%	3↑45.7%	8↑125.3%	6↓18.5%
Net Change in Cash	23	-23↓201.5%	13↑154.8%	3↓77.5%	-9↓402.6%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance